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Chapter 15
Complications of thoracic aortic endografts:
Spinal cord ischemia and stroke
Timothy M. Sullivan, MD, and Thoralf M. Sundt III, MD, Rochester, MinnINTRODUCTION
Up until the last 5 to 10 years, patients with aneurysms
of the thoracic and thoracoabdominal aorta had only one
treatment option: open surgical repair. For those patients
who could not tolerate operation because of medical co-
morbidities, continued aneurysm enlargement and even-
tual rupture was a constant—yet unpredictable—threat to
their lives. Several studies have documented improved sur-
vival rates in those patients treated surgically.1,2
Despite advances in surgical reconstruction and organ
protection, the mortality rate for elective repair of thoraco-
abdominal aortic aneurysms ranges from 4% to 21%; ad-
vanced age, renal failure, and postoperative paraplegia are
the most important risk factors predicting mortality at 30
days. In addition, for those patients age 79 with an
emergency presentation, history of diabetes mellitus, or
congestive heart failure, 30-day mortality is 50%. For aneu-
rysms isolated to the descending thoracic aorta, the risk of
paraplegia is 0% to 4% and appears to be dependent on the
extent of aorta replaced.3 A substantial number of patients
surviving the operation have prolonged, complicated
courses secondary to renal, cardiac, and pulmonary dys-
function. Perhaps the most devastating complication of
these complex procedures (for patients and their surgeons)
is paraplegia.4
A myriad of techniques have been developed to protect
the spinal cord during open surgical repair of the thoracic
and thoracoabdominal aorta, including “clamp and sew,”
distal aortic and visceral perfusion, complete cardiopulmo-
nary bypass, profound hypothermia and circulatory arrest,
direct spinal cord cooling, cerebrospinal fluid (CSF) drain-
age, and pharmacologic adjuncts; some of these principles
may be useful in preventing paraplegia at the time of
endovascular repair. When the thoracic aorta is cross-
clamped, spinal perfusion pressure decreases while CSF
pressure increases, resulting in decreased perfusion pres-
sure.
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the incidence of immediate postoperative neurologic deficit
occurred in 6.8% of patients who were operated on without
the adjuncts of CSF drainage and distal aortic perfusion,
whereas only 2.4% of those operated on with adjuncts had
this devastating complication. These authors also stressed
the importance of reimplantation of intercostal arteries,
especially in the vulnerable area between T9 and T12,
which frequently gives rise to the anterior spinal artery.
Relative hypertension in the immediate postoperative pe-
riod (maintaining mean arterial pressure between 90 and
100 mm Hg) is also advocated. Other risk factors for
paraplegia in their series included extent of aneurysmal
disease, advanced age, emergency presentation, preopera-
tive renal dysfunction, active smoking, and cerebrovascular
disease. Additionally, delayed paraplegia has been noted as
late as 2 weeks after surgery and has been successfully
treated by placement of a spinal drain.6
PARAPLEGIA AND PARAPARESIS
Substantial controversy exists with respect to elective
repair of abdominal aortic aneurysms with endografts in
good-risk patients owing to the excellent perioperative
mortality and long-term durability of open surgical repair.7
The promise of endovascular repair of thoracic aortic aneu-
rysms, however, is that of decreased perioperative mortality
and morbidity (especially with respect to paraplegia, per-
manent renal failure and stoke) in a population of patients
who heretofore did not have an alternative to open surgical
therapy or expectant treatment. Although there is a paucity
of well-controlled data upon which to base definitive state-
ments and clinical practice, a review of case series within the
available literature allows for some general assumptions to
be made.
In one of the first reported series by Dake et al8 in 1994,
13 patients were treated with homemade endovascular
stent-grafts over a 24-month period. All of the grafts were
successfully deployed, and no patients died or had stroke,
paraplegia or distal embolization. These results generated
incredible enthusiasm for this novel procedure.
Subsequent reports in larger groups of patients were,
however, more sobering. The EUROSTAR and United
Kingdom registries, reported in 2004 by Leurs et al,9
examined 443 patients who had undergone endovascular
repair of a variety of pathologies involving the thoracic
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anastomotic aneurysms, and traumatic ruptures. In the
entire cohort, 11 instances of paraplegia or paresis oc-
curred, for an incidence of 2.5%. Most of the patients with
this particular complication (10 of 11) were in the group
that had an atherosclerotic aneurysm. One patient in the
aortic dissection group and no patients in the false aneu-
rysm and traumatic rupture groups were affected. Under-
standably, given the heterogeneous nature of the patient
population and practice variability across the 62 participat-
ing centers, there are no reported data on the use of spinal
drains.
Chiesa et al10 reported on 103 patients treated elec-
tively for thoracic aortic lesions, 88 (85%) of which were
atherosclerotic aneurysms. Preoperative CSF drainage was
used in seven patients (based on data extrapolated from
their experience with open surgical repair), including those
with aneurysms involving critical intercostal arteries (T8 to
T12), those requiring coverage of a long segment of the
thoracic aorta (20 cm), and in patients with prior repair of
an abdominal aortic aneurysm. Four patients (4%) had
delayed neurologic deficit that completely resolved after
the institution of CSF drainage, systemic steroid therapy,
and pharmacologic support of blood pressure. Univariate
analysis identified only a perioperative mean arterial blood
pressure of 70 mm Hg as a significant predictor of spinal
cord ischemia (P  .0001).
Greenberg et al11 from The Cleveland Clinic prospec-
tively evaluated their results in 100 patients treated with
investigational Zenith (Cook, Bloomington, Ind) devices.
Of note, a spinal drain was placed preoperatively in 84% of
their patients. Acute spinal cord ischemia was noted in 7.4%
of 81 patients treated for atherosclerotic aneurysms, al-
though only two of these six patients had a permanent
deficit. Paraplegia or paraparesis did not develop in any
patients treated for chronic dissection with aneurysm or
other indications.
Finally, Makaroun et al12 have reported results from a
multicenter trial of the Gore TAG thoracic endograft (W. L.
Gore & Associates, Flagstaff, Ariz), the only device currently
available outside of US Food and Drug Administration-
approved clinical trials. The device was successfully im-
planted in 139 patients, and spinal drains were not rou-
tinely placed before the procedures. Either temporary or
permanent spinal cord deficit developed in four patients
(3%). One patient was found to have paraplegia immedi-
ately following the procedure that did not resolve after
placement of a spinal drain. Symptoms developed in a
second patient 6 hours after surgery, associated with an
episode of hypotension. Symptoms improved (but did not
abate entirely) after stabilization of blood pressure and
placement of a spinal drain. In the third and fourth patients,
symptoms developed on the first postoperative day; both
were ambulating at the time of their discharge.
Complications of thoracic aortic endografting, com-
piled from case series in the peer-reviewed literature (and
having at least 20 cases), are listed in Table I. Thirty-day
mortality is 0% to 19%, with a weighted average of 6.7% inthis complex patient group. Likewise, there is a broad range
in the incidence of spinal cord ischemia, from 0% to 12.5%,
with an average of 2.7% in 1895 patients. The use of spinal
drains in these citations is quite variable; some centers use
them selectively in high-risk anatomic situations, whereas
others use spinal drains only after patients become symp-
tomatic. The use of this important adjunct must be individ-
ualized, and must also be based on its safety and ease of use
at each institution. Indications for placing a spinal drain,
based on our current practice, are listed in Table II. The
drain remains in place for 24 hours in an intensive care unit
setting and is then removed. While in place, it is allowed to









Mitchell, 1999 103 9 (9) 7 (7) 3 (3)
Won, 2001 23 0 0 0
Taylor, 2001 37 3 (8) 1 (2.7) 0
White, 2001 26 1 (4) 0 1 (4)
Gravereaux, 2001 53 0 0 3 (5.6)
Cambria, 2002 28 1 (3.5) 0 0
Thompson, 2002 46 2 (4.3) 0 0
Criado, 2002 47 1 (2.1)* 0 0
Lepore, 2002 43 3 (7) 8 (18.6) 3 (6.9)
Usui, 2002 24 0 1 (4.2) 3 (12.5)
Ellozy, 2003 84 5 (6) 0 3 (3.6)
Bell, 2003 67 5 (7.4) 3 (4.5) 3 (4.5)
Chabbert, 2003 47 4 (8.5) 0 0
Krohg-Sorensen,
2003 20 2 (10) 0 0
Lambrechts, 2003 26 0 0 0
Schoder, 2003 28 0 0 0
Matravers, 2003 24 2 (7) 0 0
Lamme, 2003 21 0 0 0
Orend, 2003 74 7 (9.5) 0 2 (2.7)
Neuhauser, 2004 31 6 (19) 1 (3) 2 (6)
Bortone, 2004 132 4 (4) 0 0
Brandt, 2004 22 1 (4.5) 1 (4.5) 1 (4.5)
Leurs, 2004 443 41 (9) 10 (2.3) 11 (2.5)
Hansen, 2004 59 10 (16.9) 2 (3.4) 1 (1.7)
Makaroun, 2005 139 2 (1.5) 5 (4) 4 (3)
Chiesa, 2005 103 1 (1) 1 (1) 4 (4)
Greenberg, 2005 100 17 (17) 2 (2) 6 (6)
Melissano, 2005 45 0 0 1 (2)
Total 1895 127 (6.7) 42 (2.2) 51 (2.7)
*An additional patient died, after 30 days, of aortic rupture.
Table II. Indications for the use of cerebrospinal drains
in patients requiring thoracic endografts
1. Anticipated endograft coverage T9-T12 (location of anterior
spinal artery)
2. Coverage of long segment of thoracic aorta
3. Compromised collateral pathways (eg, previous infrarenal
aortic aneurysm repair)
4. Symptomatic spinal ischemia (in a patient who did not have a
drain placed preoperatively)drain to maintain a CSF pressure of 10 mm Hg.
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The incidence of stroke, like spinal cord ischemia, also
varies widely (Table I) and is likely multifactorial in etiol-
ogy. In the Gore TAG trial, five patients (3.5%) had this
complication, one of which was fatal; the remaining four
were disabled enough to require rehabilitation after hospi-
tal discharge. Of interest, four of the five patients had left
carotid-subclavian bypass either as a staged intervention or
part of the endograft procedure. All four had proximal
aneurysmal disease that required coverage of the left sub-
clavian to achieve adequate proximal fixation. Three of the
five strokes involved both the anterior and posterior circu-
lation. Of 28 patients having carotid-subclavian interven-
tion, four had strokes (14%), compared with 1% of patients
who did not require this adjunctive operation.
The location of these strokes and their association with
proximal aneurysmal disease implicates multiple emboli (to
the anterior and posterior circulation) arising from the
aortic arch, likely from catheter, guidewire, or endopros-
thesis manipulation in a diseased arch. Other potential
etiologies for stroke include air embolus, cervical carotid
disease, and vertebral-basilar disease (especially when the
left subclavian/vertebral is covered by the endograft and
not revascularized).
Our policy has been to evaluate the aortic arch with
transesophageal echocardiography in an attempt to identify
a “shaggy” arch or free-floating thrombus that may pre-
clude safe endograft placement. Planned endograft cover-
age of the left subclavian artery demands preoperative
confirmation of right vertebral patency; in addition, com-
puted tomography angiography or contrast angiography of
the aortic arch will identify the occasional patient in whom
the left vertebral arises as a separate branch from the arch.
Also see Chapter 12 on subclavian artery transposition and
Chapter 13 on total aortic arch debranching.
OTHER COMPLICATIONS
A myriad of other complications have been described
following placement of thoracic endografts, including fatal
access failure (iliac artery rupture), device migration, retro-
grade dissection, and aortoesophageal fistula.12-15 Postim-
plant syndrome has been described after endovascular repair
of abdominal aortic aneurysms and includes fever, pain, leu-
kocytosis, and elevation of systemic inflammatory markers.
Several reports have noted a similar scenario after endovas-
cular repair of thoracic aortic aneurysms. Schoder et al16
described fever (36%), leukocytosis (37%), pleural effusion
(50%), periaortic atelectasis (41%), and elevated C-reactive
protein (92%) in a series of 28 consecutive patients. In
another report by Won et al,17 nearly half (10/23, 43%) of
their patients had a similar postoperative course. When
associated with back pain, the suspicion of aortic leak arises,
typically necessitating urgent aortic imaging, which invari-
ably finds the endograft and the aorta to remain intact;
treatment includes anti-inflammatory agents, antibiotics,
and patient reassurance.CONCLUSION
The mechanisms of spinal cord ischemia and stroke
following endovascular treatment of thoracic aortic pathol-
ogy are likely multifactorial and remain poorly defined. A
thorough knowledge of the etiology of these complications
following open surgical repair of thoracic and thoracoab-
dominal aortic aneurysms is essential in our attempt to
prevent them after endovascular repair. Particular attention
to anatomic factors that may place patients at increased risk,
such as aneurysm extent, compromise of collateral path-
ways to the anterior spinal artery, and the presence of aortic
arch disease, may allow for modifications in technique to
decrease their incidence.
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